Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.40 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.40 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.40 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.40 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.40 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.40 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.40 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4584292 | 1.00 | MAPT (0.50) | MAPTHCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL4582554 | 0.96 | HCAR2 (0.46) | MAPTHCAR2KEAP1NFE2L2TAS1R3 | |
| SCHEMBL4939935 | 0.96 | HCAR2 (0.46) | MAPTHCAR2KEAP1NFE2L2TAS1R3 | |
| SCHEMBL4937441 | 0.94 | MAPT (0.44) | MAPTHCAR2KEAP1NFE2L2FAAH | |
| SCHEMBL4583174 | 0.94 | MAPT (0.44) | MAPTHCAR2KEAP1NFE2L2FAAH | |
| SCHEMBL18120374 | 0.92 | — | — | |
| SCHEMBL873968 | 0.92 | — | — | |
| SCHEMBL873967 | 0.92 | — | — | |
| SCHEMBL29626505 | 0.89 | HCAR2 (0.57) | MAPTHCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL11874324 | 0.88 | KEAP1 (0.46) | MAPTHCAR2KEAP1NFE2L2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | claimed |
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | DECR1, ALOX12, ALOX15 | MAPT 4488/4885HCAR2 108/4885KEAP1 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.